Obesity is the most prevalent metabolic disease today, significantly impacting public health and life expectancy due to associated conditions like type 2 diabetes and cardiovascular disease. Recent insights into the factors influencing obesity include genetic, behavioral, and environmental elements, as highlighted in a review by Catalán et al. Personalized treatment approaches are recommended, distinguishing between acquired and inherited obesity.
Key advancements in obesity management involve the use of tools like skin autofluorescence to assess cardiometabolic risks and dietary changes, particularly emphasizing the Mediterranean diet while addressing the negative impact of ultra-processed foods. Pharmacological treatments such as semaglutide show promise for effective weight loss and improved health outcomes.
The COVID-19 pandemic has increased the use of telehealth in obesity management, offering greater access to care. Additionally, innovative models like the Personalized Metabolic Avatar (PMA) provide tailored dietary strategies. While progress has been made in treating obesity, further research is essential to optimize management and enhance patients' quality of life.
Source: Gómez-Ambrosi J. Recent Progress in the Management of Obesity. Nutrients. 2023 Jun 6;15(12):2651. doi: 10.3390/nu15122651. PMID: 37375555; PMCID: PMC10302691.
Please login to comment on this article